プロモーションスケジュール Anteris Technologies Ltd
詳細なスケジュール
簡易グラフ
会社について Anteris Technologies Ltd
Anteris Technologies Ltd, a structural heart company, engages in the designing, developing, and commercializing medical devices. The company's lead product candidate is DurAVR, a transcatheter heart valve (THV) for the treatment of aortic stenosis. It also offers ComASUR, a delivery system that provides controlled deployment and placement of the DurAVR THV with balloon-expandable delivery, which allow precise alignment of the heart's native commissures to achieve ideal valve positioning; and ADAPT, a patented anti-calcification tissue technology. さらに詳しく| Industry | Health Care Equipment & Supplies |
|---|---|
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | aud |
| Сайт | https://anteristech.com |
| Цена ао | 5.7 |
| 1日あたりの価格変動: | 0% (5.7) |
|---|---|
| 週ごとの価格変動: | 0% (5.7) |
| 月ごとの料金変更: | 0% (5.7) |
| 3ヶ月間の価格変動: | -35.81% (8.88) |
| 半年間の価格変動: | -34.86% (8.75) |
| 年間の価格変動: | -51.26% (11.695) |
| 3年間の価格推移: | -55.47% (12.8) |
| 5年間の価格推移: | +7 500% (0.075) |
| 年初からの価格変動: | -28.75% (8) |
|
|
過小評価
|
効率
|
|||||||||||||||||||||||||||||||||||||
配当金
|
義務
|
成長の衝動
|
|||||||||||||||||||||||||||||||||||||
| スーパーバイザー | 役職 | 支払い | 生年 |
|---|---|---|---|
| Mr. Wayne Geoffrey Paterson | CEO, MD & Executive Director | 1967 (58 年) | |
| Mr. Matthew McDonnell | Chief Financial Officer | ||
| Mr. David St. Denis | Chief Operating Officer | ||
| Mr. Stephen Denaro | Independent Non-Executive Director & Company Secretary | ||
| Dr. Chris Meduri M.D., M.P.H. | Chief Medical Officer & Member of Medical Advisory Board |
